{"published": "2015-09-02T08:24:00Z", "media-type": "News", "title": "Biotech ETFs Up YTD But 12% Losses In August Creates Downtrend", "id": "ee517325-4c1d-48f4-8177-b90fd9d096c3", "content": "Biotech stocks were previously immune to volatility from macro events in Europe and China. Now fears from a broad emerging market downturn has curbed risk across the board spilling into the healthcare sector.", "source": "Vision Monday"}